Assessing the quality of reports about randomized controlled trials of scalp acupuncture combined with another treatment for stroke

BMC Complementary and Alternative Medicine

Volumn 17, Issue 1, 2017, Pages

  You, Young Nim ^a   Cho, Myung Rae ^b   Kim, Jae Hong ^a,b   Park, Ju Hyung ^a   Park, Gwang Cheon ^a   Song, Min Yeong ^b   Choi, Jin Bong ^b   Han, Jae Young ^c  

^a Dongshin University   (South Korea)

^b Department of Acupuncture and Moxibustion Medicine ^*  (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Consort; Randomized controlled trials; Scalp acupuncture; STRICTA; Stroke

Indexed keywords

ACUPUNCTURE; ARTICLE; AURICULAR ACUPUNCTURE; CEREBROVASCULAR ACCIDENT; CHINESE BIOMEDICAL DATABASE; CONSOLIDATED STANDARDS OF REPORTING TRIALS; ELECTROACUPUNCTURE; HEALTH CARE MANAGEMENT; HUMAN; INTENTION TO TREAT ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SCALP; SCORING SYSTEM; STANDARDS FOR REPORTING INTERVENTIONS IN CONTROLLED TRIALS OF ACUPUNCTURE; STUDY DESIGN; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; PHYSIOLOGY; PROCEDURES; STANDARDS; STROKE;

ACUPUNCTURE THERAPY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCALP; STROKE;

EID: 85028932905     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-017-1950-6     Document Type: Article

References (48)

1. Korea S. Life Tables [In Korean]. 2013:2014. http://kostat.go.kr/portal/korea/kor_ko/5/2/index.board?bmode=read&aSeq=332455. Accessed 31 Mar 2016
2. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med. 2005;353:1124-34.
3. Feigin VL. Stroke epidemiology in the developing world. Lancet. 2005;365:2160-1.
4. Lee WH, Kim JS. A review study of stroke in Korea. Korean J Epidemiol. 1981;3:1-22.
5. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D, et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999;281:1112-20.
6. Liu Z, Guan L, Wang Y, Xie CL, Lin XM, Zheng GQ. History and mechanism for treatment of intracerebral hemorrhage with scalp acupuncture. Evid Based Complement Alternat Med. 2012;2012:895032.
7. WHO Scientific Group on International Acupuncture Nomenclature. A proposed standard international acupuncture nomenclature. Report of a WHO scientific group. Geneva: World Health Organization; 1991.
8. Dharmananda S, Vickers E. Synopsis of scalp acupuncture. 2000. http://www.itmonline.org/arts/newscalp.htm Accessed 31 Mar 2016.
9. Beak KM, Kim MJ, Lee HU, Lim SM, Yoo HR, Jo HK, et al. A clinical study of 3 cases of stroke patients with dysphagia treated by simultaneous scalp-acupuncture and electroacupuncture. Korean J Orient Int Med. 2007;28:632-44.
10. Cho TS, Son IS, Park IB, Kim SW, Seo JC, Youn HM, et al. Effects of scalp acupuncture on short-term NIHSS and MBI in stroke patients. J Korean Orient Med. 2003;24:65-73.
11. Ha CH, Han SG, Cho MR, Ryu CR, Lee BR. A clinical study on 29 cases with stroke treated by body acupuncture therapy and scalp acupuncture. J Korean Acupunct Moxibust Soc. 2001;18:82-90.
12. Kim JH, Park GC. A case report of central post-stroke pain patient treated with SA (MS6 and MS7) and usual treatment of Korean medicine. J Korean Acupunct Moxibust Soc. 2014;31:57-65.
13. Wang Y, Shen J, Wang X-M, Fu D-L, Chen C-Y, Lu L-Y, et al. Scalp acupuncture for acute ischemic stroke: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2012;2012:1-9.
14. Lee SJ, Shin BC, Lee MS, Han CH, Kim JI. Scalp STRICTA recommendations for stroke recovery: a systematic review and meta-analysis of randomized controlled trials. Eur J Integr Med. 2013;5:87-99.
15. Kong JC, Lee MS, Shin BC, Song YS, Ernst E. Acupuncture for functional recovery after stroke: a systematic review of sham-controlled randomized clinical trials. CMAJ. 2010;182:1723-9.
16. Son C. Overview for pattern and results of moxibustion-derived clinical trials. J Meridian Acupoint. 2009;26:41-9.
17. Chung W, Lee KW, Hwang IH, Lee DH, Kim SY. Quality assessment of randomized controlled trials in the journal of the Korean academy of family medicine. Korean J Fam Med. 2009;30:626-31.
18. Park J, Kang K, Choi S. Assessing methodological quality of acupuncture clinical trials of Korea. J Korean Acupunct Moxibust Soc. 2007;24:127-35.
19. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726-32. https://doi.org/10.7326/0003-4819-152-11-201006010-00232.
20. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, et al. Revised STandards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. PLoS Med. 2010;7:e1000261.
21. Zhuang L, He J, Zhuang X, Lu L. Quality of reporting on randomized controlled trials of acupuncture for stroke rehabilitation. BMC Complement Altern Med. 2014;14:151.
22. The Chinese Medical Association of the Fourth National Cerebrovascular Disease Conference. Essentials of diagnosis of all kinds of cerebrovascular diseases. Chin J Neurol. 1996;29:379.
23. Li P, Wu ZZ, Zhang YR, Li BZ, Hua RC, Wei JN, et al. Criterion of diagnosis and therapeutic effect of apoplexy. J Beijing Univ Tradit Chin Med. 1996;19:55-6.
24. The Forth National Cerebrovascular Diseases Conference. Classification, diagnostic criteria and evaluation of neurological impairment for stroke patients. Chin J Neurol. 1996;29:381-3.
25. Chen ZW, Chen YC, Zeng JC, Wang Y, Ye T, Zhou QC, et al. Quality of randomized controlled trials reporting in the treatment of melasma conducted in China. Trials. 2015;16:156.
26. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ. 1999;319:670-4.
27. Gluud LL, Thorlund K, Gluud C, Woods L, Harris R, Sterne JA. Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2008;149:219.
28. Montori VM, Bhandari M, Devereaux PJ, Manns BJ, Ghali WA, Guyatt GH. In the dark: the reporting of blinding status in randomized controlled trials. J Clin Epidemiol. 2002;55:787-90.
29. Gao J, Deng G, Hu Y, Huang Y, Lu L, Huang D, et al. Quality of reporting on randomized controlled trials on recurrent spontaneous abortion in China. Trials. 2015;16:172.
30. Lai R, Chu R, Fraumeni M, Thabane L. Quality of randomized controlled trials reporting in the primary treatment of brain tumors. J Clin Oncol. 2006;24:1136-44.
31. Lu X, Hongcai S, Jiaying W, Jing H, Jun X. Assessing the quality of reports about randomized controlled trials of acupuncture treatment on mild cognitive impairment. PLoS One. 2011;6:e16922.
32. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomized trials. BMJ. 2010;340:c869.
33. Mcdonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, et al. What influences recruitment to randomized controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006;7:9.
34. Chen X, Zhai X, Wang X, Su J, Li M. Methodological reporting quality of randomized controlled trials in three spine journals from 2010 to 2012. Eur Spine J. 2014;23:1606-11.
35. Tukey JW. Some thoughts on clinical trials, especially problems of multiplicity. Science. 1977;117:916-21.
36. Hahn S, Williamson PR, Hutton JL, Garner P, Flynn EV. Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies. Stat Med. 2000;19:3325-36.
37. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 1999;281:1110-1.
38. Scharf O, Colevas AD. Adverse event reporting in publications compared with sponsor database for cancer clinical trials. J Clin Oncol. 2006;24:3933-8.
39. Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med. 2009;169:1756-61.
40. Bo C, Xue Z, Yi G, Zelin C, Yang B, Zixu W, et al. Assessing the quality of reports about randomized controlled trials of acupuncture treatment on diabetic peripheral neuropathy. PLoS One. 2012;7:e38461.
41. Lee HS, Cha SJ, Park HJ, Seo JC, Park JB, Lee HJ. Revised STandards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. Korean J Acupunct. 2010;27:1-23.
42. Di Blasi Z. Kleijnen J. Context effects. Powerful therapies or methodological bias? Eval Health Prof. 2003;26:166-79.
43. Baer H. The emergence of integrative medicine in Australia: the growing interest of biomedicine and nursing in complementary medicine in a southern developed society. Med Anthropol Q. 2008;22:52-66.
44. Lu L, Liao M, Zeng J, He J. Quality of reporting and its correlates among randomized controlled trials on acupuncture for cancer pain: application of the CONSORT 2010 statement and STRICTA. Expert Rev Anticancer Ther. 2013;13:489-98.
45. Tang JL, Zhan SY, Ernst E. Review of randomized controlled trials of traditional Chinese medicine. BMJ. 1999;319:160-1.
46. Lu L, Zeng J, Chen Y. Quality of reporting in randomized controlled trials conducted in China on the treatment of cancer pain. Expert Rev Anticancer Ther. 2011;11:871-7.
47. Chen B, Liu J, Zhang C, Li M. A retrospective survey of quality of reporting on randomized controlled trials of metformin for polycystic ovary syndrome. Trials. 2014;15:128.
48. Chen B, Zhao X, Guo Y, Chen Z, Bai Y, Wang Z, Wang Y. Assessing the quality of reports about randomized controlled trials of acupuncture treatment on diabetic peripheral neuropathy. PLoS One. 2012;7:e38461.